|Bloom Burton||David Martin, Ph.D.|
|Cantor Fitzgerald||Alethia Young|
|HC Wainwright||Ed Arce|
|Jefferies||Maury Raycroft, Ph.D.|
|Mackie Capital Research||Andre Uddin|
|RBC Capital Markets||Douglas Miehm|
|SVB Leerink||Joseph Schwartz|
Aurinia Pharmaceuticals Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Aurinia Pharmaceuticals Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Aurinia Pharmaceuticals Inc. or its management. Aurinia Pharmaceuticals Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.